We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+16.39%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.4B
AUM Growth
+$319M
Cap. Flow
-$190M
Cap. Flow %
-2.98%
Top 10 Hldgs %
23.07%
Holding
289
New
50
Increased
129
Reduced
80
Closed
21

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$95.2M
2
VRNA
Verona Pharma
VRNA
+$72.7M
3
GH icon
Guardant Health
GH
+$72.5M
4
CELC icon
Celcuity
CELC
+$63.7M
5
EVH icon
Evolent Health
EVH
+$53.2M

Sector Composition

Rank Sector Weight
1 Healthcare 42.37%
2 Industrials 17.69%
3 Technology 15.85%
4 Consumer Discretionary 6.94%
5 Utilities 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIV icon
276
F5
FFIV
$22.9B
-8,588
Closed -$2.77M
LFUS icon
277
Littelfuse
LFUS
$11.2B
-28,882
Closed -$7.48M
LW icon
278
Lamb Weston
LW
$7.22B
-6,643
Closed -$370K
OCUL icon
279
Ocular Therapeutix
OCUL
$1.79B
-598,000
Closed -$6.99M
PAYC icon
280
Paycom
PAYC
$7.64B
-1,796
Closed -$392K
PRCT icon
281
Procept Biorobotics
PRCT
$1.06B
-468,476
Closed -$16.7M
RGEN icon
282
Repligen
RGEN
$7.96B
-77,711
Closed -$10.4M
RRC icon
283
Range Resources
RRC
$9.38B
-263,038
Closed -$9.9M
SLNO
284
DELISTED
Soleno Therapeutics
SLNO
-467,435
Closed -$31.6M
SNV
285
DELISTED
Synovus
SNV
-11,256
Closed -$555K
SWKS icon
286
Skyworks Solutions
SWKS
$9.37B
-8,648
Closed -$666K
TW icon
287
Tradeweb Markets
TW
$21.4B
-2,676
Closed -$298K
VRNA
288
DELISTED
Verona Pharma
VRNA
-680,929
Closed -$72.7M
MTSR
289
DELISTED
Metsera Inc
MTSR
-396,160
Closed -$20.7M

Similar funds

Eventide Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Eventide Asset Management held 289 positions worth $6.4B, up 5.3% from $6.08B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Eventide Asset Management's Q4 2025 filing shows 50 new, 129 increased, 80 reduced and 21 closed positions. Its largest new stake was Ionis Pharmaceuticals: 575,000 shares worth $45.5M. The largest sale was Insmed, an estimated $95.2M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Industrials and Technology.

  • Eventide Asset Management's largest Q4 2025 buy was Ionis Pharmaceuticals: 575,000 shares worth $45.5M.
  • Eventide Asset Management added most to Monolithic Power Systems in Q4 2025, an estimated $26.1M increase.
  • Eventide Asset Management's biggest Q4 2025 reduction was Insmed, cutting an estimated $95.2M.
  • Eventide Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $72.7M.
  • Eventide Asset Management's ten largest holdings make up 23% of its $6.4B portfolio in Q4 2025.
  • Eventide Asset Management opened 50 new positions and closed 21 in Q4 2025.
  • Eventide Asset Management's portfolio value rose 5.3% quarter-over-quarter to $6.4B.

Based on Eventide Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.